Company / EPS (Diluted)
MANNKIND CORP EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.04
FY2025
5-year range
-$0.34 / -$0.04
FY2021-FY2025
Trend
+88.2%
vs FY2024
Sector context
#48 of 204
Health Care
What the data says
MANNKIND CORP's eps (diluted) of $-0.04 is higher than 76% of companies in the Health Care sector (FY2025). EPS (Diluted) returned to growth in FY2025 after 2 years of decline, reaching $-0.04.
Based on SEC 10-K filings.
-0.04 in FY2025. Top quartile in the Health Care sector.
Improved from $-0.32 to $-0.04 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 204This company -$0.04 Sector average -$1.03
▼
+96.1% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 88.2% year-over-year.
- Ranks #48 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2018.
- Lowest eps (diluted) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.04 | +88.2% |
| FY2024 | -$0.34 | -6.3% |
| FY2023 | -$0.32 | -23.1% |
| FY2022 | -$0.26 | +0.0% |
| FY2021 | -$0.26 | +3.7% |
| FY2020 | -$0.27 | +55.0% |
| FY2019 | -$0.60 | -144.1% |
| FY2018 | $1.36 | +130.0% |
| FY2017 | -$4.54 | -76.7% |
| FY2016 | -$2.57 | -301.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026